InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,618.48
(
0.74%
)
US TECH 100
20,098.40
(
0.94%
)
Dow Jones
39,524.64
(
0.59%
)
Brent Oil
84.92
(
0.26%
)
Bitcoin
57,582.21
(
-0.75%
)
Post# of 7536
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

kei

Send PM Follow Ignore
Followers 306
Posts 22916
Boards Moderated 0
Alias Born 10/10/2007

kei

Re: kei post# 3797

Wednesday, 08/02/2017 10:08:53 AM

Wednesday, August 02, 2017 10:08:53 AM

Post# of 7536
AMRN up big---> Q2 Vascepa net rev ~$45M. DMC interim efficacy analysis of REDUCE-IT trial in Q3. http://globenewswire.com/news-release/2017/08/02/1070798/0/en/Amarin-Reports-Second-Quarter-2017-Financial-Results-and-Provides-Update-on-Operations.html …

°°° (\__/) (\_(\ ° ° °
°°° (='.'=) (=' :') °°°
°°° (")_(") (,(')(')°°°
°°° °°° °°° °°° °°°


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up